-
1
-
-
84857872351
-
The remaining challenges of pneumococcal disease in adults
-
Ludwig E, Bonanni P, Rohde G, et al. The remaining challenges of pneumococcal disease in adults. Eur Respir Rev 2012; 21: 57-65.
-
(2012)
Eur Respir Rev
, vol.21
, pp. 57-65
-
-
Ludwig, E.1
Bonanni, P.2
Rohde, G.3
-
2
-
-
70350498834
-
Pathogenesis, treatment, and prevention of pneumococcal pneumonia
-
van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009; 374: 1543-1556.
-
(2009)
Lancet
, vol.374
, pp. 1543-1556
-
-
van der Poll, T.1
Opal, S.M.2
-
4
-
-
84855204394
-
Clinical and economic burden of community-acquired pneumonia among adults in Europe
-
Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012; 67: 71-79.
-
(2012)
Thorax
, vol.67
, pp. 71-79
-
-
Welte, T.1
Torres, A.2
Nathwani, D.3
-
5
-
-
0043269792
-
An international prospective study of pneumococcal bacteremia: Correlation with in vitro resistance, antibiotics administered, and clinical outcome
-
Yu VL, Chiou CC, Feldman C, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003; 37: 230-237.
-
(2003)
Clin Infect Dis
, vol.37
, pp. 230-237
-
-
Yu, V.L.1
Chiou, C.C.2
Feldman, C.3
-
6
-
-
33750346251
-
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumo-coccal disease: A matched case-control study
-
Whitney CG, Pilishvili T, Farley MM, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumo-coccal disease: a matched case-control study. Lancet 2006; 368: 1495-1502.
-
(2006)
Lancet
, vol.368
, pp. 1495-1502
-
-
Whitney, C.G.1
Pilishvili, T.2
Farley, M.M.3
-
7
-
-
46249112163
-
Pneumococcal vaccines: Mechanism of action, impact on epidemiology and adaption of the species
-
Pletz MW, Maus U, Krug N, et al. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Int J Antimicrob Agents 2008; 32: 199-206.
-
(2008)
Int J Antimicrob Agents
, vol.32
, pp. 199-206
-
-
Pletz, M.W.1
Maus, U.2
Krug, N.3
-
8
-
-
77952300034
-
The effect of age on the response to the pneumococcal polysaccharide vaccine
-
Lee H, Nahm MH, Kim KH. The effect of age on the response to the pneumococcal polysaccharide vaccine. BMC Infect Dis 2010; 10: 60.
-
(2010)
BMC Infect Dis
, vol.10
, pp. 60
-
-
Lee, H.1
Nahm, M.H.2
Kim, K.H.3
-
9
-
-
55049089930
-
Rationale and design of CAPITA: A RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults
-
Hak E, Grobbee DE, Sanders EA, et al. Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults. Neth J Med 2008; 66: 378-383.
-
(2008)
Neth J Med
, vol.66
, pp. 378-383
-
-
Hak, E.1
Grobbee, D.E.2
Sanders, E.A.3
-
10
-
-
42549087356
-
Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: Conjugate vaccine elicits improved antibacterial immune responses and immunological memory
-
de Roux A, Schmöle-Thoma B, Siber GR, et al. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis 2008; 46: 1015-1023.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 1015-1023
-
-
de Roux, A.1
Schmöle-Thoma, B.2
Siber, G.R.3
-
11
-
-
77749316814
-
Increased risk of hospitali-zation for acute lower respiratory tract infection among Australian indigenous infants 5-23 months of age following pneumococcal vaccination: A cohort study
-
O'Grady KA, Lee KJ, Carlin JB, et al. Increased risk of hospitali-zation for acute lower respiratory tract infection among Australian indigenous infants 5-23 months of age following pneumococcal vaccination: a cohort study. Clin Infect Dis 2010; 50: 970-978.
-
(2010)
Clin Infect Dis
, vol.50
, pp. 970-978
-
-
O'Grady, K.A.1
Lee, K.J.2
Carlin, J.B.3
|